Verastem (VSTM) Amortizatization of Intangibles (2014 - 2018)
Verastem's (VSTM) quarterly Amortizatization of Intangibles came in at $95000.0 in Q2 2018, up 61.02% year-on-year from $59000.0 in Q2 2017, and up 14.46% quarter-over-quarter from $83000.0 in Q1 2018.
Verastem (VSTM) Amortizatization of Intangibles (2014 - 2018) Analysis & Trends
Verastem's Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $95000.0 for Q2 2018.
- On a quarterly basis, Amortizatization of Intangibles rose 61.02% year-over-year to $95000.0 in Q2 2018; TTM through Jun 2018 was $296000.0, a 419.3% increase from a year earlier, with the FY2017 full-year figure at $223000.0, up 259.29% from the prior year.
- Amortizatization of Intangibles grew to $95000.0 in Q2 2018 per VSTM's latest filing, from $83000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $478000.0 in Q4 2015 and bottomed at -$80000.0 in Q2 2016.
- The 5-year median for Amortizatization of Intangibles is -$5000.0 (2016), against an average of $24187.5.
- Across the five-year window, Amortizatization of Intangibles slumped 99.58% in 2016 and surged 2550.0% in 2017, its largest moves.
- Year by year, Amortizatization of Intangibles stood at -$60000.0 in 2014, then soared by 896.67% to $478000.0 in 2015, then slumped by 99.58% to $2000.0 in 2016, then jumped by 2550.0% to $53000.0 in 2017, then jumped by 79.25% to $95000.0 in 2018.
- Per Business Quant, the three latest VSTM Amortizatization of Intangibles figures stand at $95000.0 (Q2 2018), $83000.0 (Q1 2018), and $53000.0 (Q4 2017).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Verastem | 607.94 Mn | 410.11 Mn | 15.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 95,000.00 |
| Jun 30, 2018 | 95,000.00 |
| Mar 31, 2018 | 83,000.00 |
| Mar 31, 2018 | 83,000.00 |
| Dec 31, 2017 | 53,000.00 |
| Dec 31, 2017 | 53,000.00 |
| Sep 30, 2017 | 65,000.00 |
| Sep 30, 2017 | 65,000.00 |
| Jun 30, 2017 | 59,000.00 |
| Jun 30, 2017 | 59,000.00 |
| Mar 31, 2017 | 46,000.00 |
| Mar 31, 2017 | 46,000.00 |
| Dec 31, 2016 | 2,000.00 |
| Dec 31, 2016 | 2,000.00 |
| Sep 30, 2016 | -50,000.00 |
| Sep 30, 2016 | -50,000.00 |
| Jun 30, 2016 | -80,000.00 |
| Jun 30, 2016 | -80,000.00 |
| Mar 31, 2016 | -12,000.00 |
| Mar 31, 2016 | -12,000.00 |